Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Jasper Therapeutics, Inc.

NASDAQ: JSPR · Life Sciences · 11 alerts · CIK 1788028

Share price
$11.77Close, Nov 16
Market cap
$13.1M
Shares outstanding
1.11MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jasper Therapeutics, Inc. filings on SEC EDGAR ↗

6:01 AM ET 8-K/A
M&A Deal

Jasper Therapeutics M&A Deal with Kira Pharmaceuticals

Jasper Therapeutics filed an amendment to provide required financial statements and pro forma information regarding its completed acquisition of Kira Pharmaceuticals. The deal involved the issuance of approximately 5.2 million common shares and 4.6 million preferred shares to Kira shareholders, alongside a concurrent $132 million private placement financing.

Counterparty
Kira Pharmaceuticals
5:29 PM ET 8-K/A
M&A Deal

Jasper Therapeutics M&A Deal with Kira Pharmaceuticals

Jasper Therapeutics, Inc. filed an amendment to its previous 8-K to include required financial statements and pro forma information following its completed acquisition of Kira Pharmaceuticals. The transaction was structured as a merger where Kira merged into a wholly owned subsidiary of Jasper, and the filing also references a concurrent private placement of preferred stock and a license agreement with Mirador.

Counterparty
Kira Pharmaceuticals

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.